drugset / Trial / NCT07599046
Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
Investigation of the efficacy of fecal microbiota transplantation added to calorie-restricted diet and semaglutide versus calorie-restricted diet and semaglutide alone for weight loss and metabolic improvement in patients with moderate to severe obesity and type 2 diabetes mellitus.
Timeline
- Start
- 2026-04-30
- Primary completion
- 2027-01-30
- Completion
- 2029-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ornidazole | Other / unclassified | 10 unknown | Oral |
| Subject | Semaglutide | Peptide | 1 mg | Subcutaneous |